A Prospective, Cohort, and Observational Study of the Effect of Integrated Diagnosis and Treatment of Chronic Kidney Disease (CKD) on Clinical Outcomes in Real World Clinical Practice

What this Trial Is About

Researchers are conducting an observational study to follow a group of patients with Chronic Kidney Disease (CKD) to evaluate how well integrated diagnosis and treatment based on guidelines is being applied in real-world clinical practice. The study aims to understand the clinical outcomes of patients with different risk levels by analyzing long-term follow-up data. This research focuses on CKD patients who may also have conditions like hypertension, hyperglycemia, hyperlipidemia, anemia, mineral and bone disorders, and malnutrition. The study divides participants into two groups: those receiving integrated diagnosis and treatment according to established guidelines, which includes regular monitoring and management of blood pressure, blood glucose, lipids, anemia, bone metabolism, nutrition, acid-base balance, electrolytes, diet, and exercise; and those receiving less comprehensive or unintegrated care. The integrated care group follows recommendations from Kidney Disease Improving Global Outcomes and the Chinese Medical Association guidelines during their follow-up period. Participants will be followed over time with ongoing clinical monitoring to assess outcomes such as the rate of cardiovascular and cerebrovascular adverse events, as well as all-cause mortality, measured over six months or longer. The research involves collecting data on how well integrated care is implemented in practice and analyzing risk factors to help improve CKD diagnosis, treatment quality, and patient prognosis. The observation will provide valuable data to support continuous improvement in CKD management in real-world settings.

Integrated Diagnosis and Treatment of CKD on Outcomes